Corona Remedies Ltd
BSE: 544644
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 |
|---|---|---|---|
| INCOME | |||
| Revenue | 353.09+3.1% | 342.42-5.2% | 361.13 |
| Other Income | 4.11+83.5% | 2.24-1.3% | 2.27 |
| Total Income | 357.20+3.6% | 344.66-5.2% | 363.40 |
| EXPENSES | |||
| Expenditure | 302.74+12.0% | 270.37-8.0% | 293.79 |
| Tax | 9.41-32.5% | 13.94-20.2% | 17.46 |
| PROFIT | |||
| PBT | 54.46-1.3% | 55.19-20.7% | 69.61 |
| Net Profit | 45.05+9.2% | 41.25-20.9% | 52.15 |
| KEY METRICS | |||
| OPM % | 17.56%-1.15pp | 18.71%-3.02pp | 21.73% |
| NPM % | 12.61%+0.64pp | 11.97%-2.38pp | 14.35% |
| EPS | 7.37+9.3% | 6.74-21.0% | 8.53 |
Corporate Events
Board MeetingCORONA
20269Jul
Board Meeting
The 22nd Annual General Meeting (AGM) of the Company is sche…
BSE Filing ↗ Board MeetingCORONA
20269Jul
Board Meeting
The 22nd Annual General Meeting (AGM) of the Company is sche…
BSE Filing ↗